CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in the following upcoming investor conferences:
Read more at globenewswire.comDesign Therapeutics to Participate in Multiple Upcoming Investor Conferences
DESIGN THERAPEUTICS INC
NASDAQ:DSGN (2/11/2025, 12:39:52 PM)
3.82
-0.44 (-10.33%)
DSGN Latest News and Analysis
a day ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
